SIC 2835
In Vitro & In Vivo Diagnostic Substances
63 tracked issuers · live filings below.
Tracked issuers
63
Recent filings surfaced
40
SIC code
2835
Industry overview
Covering makers of reagents, assay kits, biomarkers, and companion diagnostics for lab benches and animal models, SIC 2835 serves hospitals, clinical reference labs, biotech and pharma R&D teams, and contract research organizations that rely on precise in vitro and in vivo diagnostic substances to validate therapies and guide patient care. Firms balance innovation with strict oversight from FDA/EMA pathways, CLIA compliance, data integrity rules, reimbursement scrutiny, and supply-chain or contamination risks that can erode assay reliability and margins. The 2024-2025 landscape is defined by multiplex and point-of-care platforms, AI-augmented analysis, liquid biopsy targets, and personalized medicine partnerships that demand robust quality systems and transparent performance claims. Competitive differentiation hinges on sensitivity, speed, and integration with digital workflows while managing cost pressures and evolving EU IVDR timelines. Track how market leaders navigate these dynamics and view live SEC filings on EarningsFeed to spot emerging moves in this tightly regulated niche.
Source: Earnings Feed research · last fetched 11/23/2025
Featured issuers
- ABLE LABORATORIES INC
CIK 0000857171
DE
- ACCUMED INTERNATIONAL INC
CIK 0000888335
DE
- ACHIEVE LIFE SCIENCES, INC.
CIK 0000949858 · ACHV
DE
- ALERE SAN DIEGO, INC.
CIK 0000834306
DE
- ALLIANCE PHARMACEUTICAL CORP.
CIK 0000736994
NY
- ANSYS DIAGNOSTICS INC
CIK 0001068965
DE
- AQUILA BIOPHARMACEUTICALS INC
CIK 0000704292
DE
- AVIGEN INC \DE
CIK 0000932903
DE
- Anbio Biotechnology
CIK 0001982708 · NNNN
E9
- Aspira Women's Health Inc.
CIK 0000926617 · AWHL
DE
- BCAM INTERNATIONAL INC
CIK 0000856143
NY
- BIOCIRCUITS CORP
CIK 0000855844
DE
Recent filings
Cardio Diagnostics Holdings, Inc. 10-Q
5.3 MBTECHNICAL CHEMICALS & PRODUCTS INC 8-K
56.0 KBGENZYME DEVELOPMENT PARTNERS L P 10-Q
38.4 KB